Hamilton Health Sciences-Juravinski Cancer Centre

Hamilton L8V5C2

4 studies enrolling now · 5 studies all time

What they study most

Breast Neoplasms, Carcinoma, Transitional Cell, Extensive Stage Small Cell Lung Cancer (ES-SCLC), Fallopian Tube Neoplasms, Neoplasm Metastasis, Newly Diagnosed Glioblastoma, Ovarian Neoplasms, Peritoneal Neoplasms, Urinary Bladder Neoplasms

Studies at this site

• A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA) — Recruiting now
• A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer — Recruiting now
• Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung Cancer — Recruiting now
• A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract — Recruiting now
• A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma — Completed